SCHEMBL2116439

SCHEMBL2116439

CC(C)(C)N(C(=O)O)C1=NC2(c3c(F)ccc(N)c3F)CCCCC2CS1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.35
BACE2 Q9Y5Z0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2107233 1.00 BACE1 (0.35) BACE1BACE2
SCHEMBL2118897 0.84 BACE1 (0.44) BACE1BACE2
SCHEMBL2108438 0.84 BACE1 (0.44) BACE1BACE2
SCHEMBL2108559 0.83 BACE1 (0.44) BACE1BACE2
SCHEMBL2117460 0.83 BACE1 (0.44) BACE1BACE2
SCHEMBL2107743 0.83 BACE1 (0.39) BACE1BACE2
SCHEMBL2117992 0.83 BACE1 (0.39) BACE1BACE2
SCHEMBL2118648 0.82 BACE1 (0.37) BACE1BACE2
SCHEMBL2109108 0.82 BACE1 (0.37) BACE1BACE2
SCHEMBL2117224 0.81 BACE1 (0.47) BACE1BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120094984-A1 FUSED AMINODIHYDROTHIAZINE DERIVATIVES EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120094984-A1 FUSED AMINODIHYDROTHIAZINE DERIVATIVES BACE1, APP, BACE2 BACE1 1/4885BACE2 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.